Researchers
- NISHIDA Naoshi
- Clinical Professor
Faculty | Department of Medicine / Graduate School of Medical Sciences |
---|---|
Researchmap | https://researchmap.jp/naoshinishida |
Education and Career
Education
- - 1985 , Osaka Medical College, Faculty of Medicine,
- - 1993 , Kyoto University, Graduate School of Medicine,
Academic & Professional Experience
- Apr. 2021 - Today , Kindai University Faculty of Medicine Professor
- Aug. 2011 - Mar. 2021 , Fuculty of Medicine Kindai University Department of Gastroenterology and Hepatology Associate Professor
- Aug. 2006 - Jul. 2011 , Kyoto University Graduate School of Medicine Department of Gastroenterology and Hepatology Assistant Professor/Lecture
- Feb. 2004 - Jul. 2006 , Baylor University Medical Center Division of Gastroenterology Reserach Associate
- Apr. 1997 - Jan. 2004 , Kyoto University Graduate School of Medicine Department of Medicine and Clinical Science Assistant Professor
- May. 1996 - Apr. 1997 , Research Institute for Production Development Researcher
Research Activities
Research Areas
- Informatics, Biological, health, and medical informatics
- Life sciences, Genomics
- Life sciences, Gastroenterology
Research Interests
data base, artificial Intelligence, Molecular Biology, Hepatology, Gastroenterology, Epigenetics, chromosome, tumor suppressor gene, Hepatocellular carcinoma
Published Papers
-
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Margherita Rimini; Bernardo Stefanini; Toshifumi Tada; Goki Suda; Shigeo Shimose; Masatoshi Kudo; Fabian Finkelmeier; Changhoon Yoo; José Presa; Elisabeth Amadeo; Virginia Genovesi; Maria Caterina De Grandis; Massimo Iavarone; Fabio Marra; Francesco Foschi; Emiliano Tamburini; Federico Rossari; Francesco Vitiello; Linda Bartalini; Caterina Soldà; Francesco Tovoli; Caterina Vivaldi; Sara Lonardi; Marianna Silletta; Takashi Kumada; Naoya Sakamoto; Hideki Iwamoto; Tomoko Aoki; Vera Himmelsbach; Margarida Montes; Atsushi Hiraoka; Takuya Sho; Takashi Niizeki; Naoshi Nishida; Christoph Steup; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Ochi; Satoshi Yasuda; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Noritomo Shimada; Kazuhito Kawata; Fujimasa Tada; Hideko Ohama; Kazuhiro Nouso; Asahiro Morishita; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Michitaka Imai; Hisashi Kosaka; Atsushi Naganuma; Yohei Koizumi; Shinichiro Nakamura; Masaki Kaibori; Hiroko Iijima; Yoichi Hiasa; Mara Persano; Silvia Camera; Silvia Foti; Luca Aldrighetti; Stefano Cascinu; Andrea Casadei-Gardini; Fabio Piscaglia
Liver international : official journal of the International Association for the Study of the Liver 22, Mar. 2024 , Refereed -
Hereditary hemorrhagic telangiectasia with hepatic arteriovenous shunt diagnosed due to liver damage
Satoru Hagiwara; Toru Takase; Itsuki Oda; Yoriaki Komeda; Naoshi Nishida; Akihiro Yoshida; Tomoki Yamamoto; Takuya Matsubara; Masatoshi Kudo
Clinical Journal of Gastroenterology 4, Mar. 2024 -
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma.
Lorenz Balcar; Bernhard Scheiner; Claudia Angela Maria Fulgenzi; Antonio D'Alessio; Katharina Pomej; Marta Bofill Roig; Elias Laurin Meyer; Jaekyung Che; Naoshi Nishida; Pei-Chang Lee; Linda Wu; Celina Ang; Anja Krall; Anwaar Saeed; Bernardo Stefanini; Antonella Cammarota; Tiziana Pressiani; Yehia I Abugabal; Shadi Chamseddine; Brooke Wietharn; Alessandro Parisi; Yi-Hsiang Huang; Samuel Phen; Caterina Vivaldi; Francesca Salani; Gianluca Masi; Dominik Bettinger; Arndt Vogel; Johann von Felden; Kornelius Schulze; Marianna Silletta; Michael Trauner; Adel Samson; Henning Wege; Fabio Piscaglia; Peter R Galle; Rudolf Stauber; Masatoshi Kudo; Amit G Singal; Aleena Itani; Susanna V Ulahannan; Neehar D Parikh; Alessio Cortellini; Ahmed Kaseb; Lorenza Rimassa; Hong Jae Chon; David J Pinato; Matthias Pinter
JHEP reports : innovation in hepatology 6 (2) , 100982-100982, Feb. 2024 , Refereed
Books etc
- Immunotherapy in Hepatocellular Carcinoma , Naoshi Nishida; Masatoshi Kudo , MDPI Books , Apr. 2023
- Treatment of HCC using Atezolizumab+Bevacizumab , Naoshi Nishida , TME and immune checkpoint inhibitors , TME and immune checkpoint inhibitors , アークメディア , Sep. 2021
- AI diagnosis for Ultrasonography , Naoshi Nishida , Chapter 9 今後の課題と展望 , Chapter 9 今後の課題と展望 , オーム社 , Sep. 2021
Conference Activities & Talks
- Development and Prospects of AI-aided Ultrasonography (US) System - New Possibilities in Diagnosis of Liver Tumor - , Naoshi Nishida , The 33rd Annual Meeting of APASL (Asian Pacific Association for Study of the Liver): Bridging Clinical and Basic Research , 29, Mar. 2024
- The roles of angiogenesis inhibitors and immune checkpoint inhibitors in the treatment of liver cancer. , Naoshi Nishida , 第6回 中外HCCWEBセミナー 特別講演 , 7, Mar. 2024
- AI支援による超音波検査システムの開発と展望 ―肝腫瘤診断における新たな可能性― , Naoshi Nishida , 第42回東海超音波研究会 特別講演 , 28, Jan. 2024
MISC
- AIを基盤とした超音波検査の未来像 肝腫瘤診断における新たな可能性と展望 , 西田 直生志 , 日本がん検診・診断学会誌 , 31 , 1 , 98 , 98 , Jun. 2023
- B型肝炎診療の未来予想図(現状と課題) 免疫チェックポイント阻害剤投与に伴うHBV再活性化および抗ウイルス効果についての検討 , 萩原 智; 西田 直生志; 工藤 正俊 , 肝臓 , 64 , Suppl.1 , A51 , A51 , Apr. 2023
- 遺伝・代謝性肝疾患の未来予想図(現状と課題) Erythropoietic porphyria(EPP)関連肝障害における瀉血治療の有効性 , 萩原 智; 西田 直生志; 工藤 正俊 , 肝臓 , 64 , Suppl.1 , A111 , A111 , Apr. 2023
Awards & Honors
- Jun. 2022, The Japan Society of Hepatology, Hepatology Research Citation Award
- Apr. 2021, Smoking Resarch Foundation, Research Grant
- Apr. 2020, National Institute of Informatics, ROIS NII Open Collaborative Research 2020
Research Grants & Projects
- 日本学術振興会, 科学研究費助成事業, 胆道癌のドライバー変異に着目した腫瘍免疫微小環境の再構築と治療最適化 , 近畿大学
- 日本学術振興会, 科学研究費助成事業, 免疫チェックポイント阻害剤投与に伴う急速な腫瘍増大(HPD)の発症機序の解析 , 近畿大学
- Smoking Research Foundation, 一般研究, Analysis of immunological microenvironment of tumor and effect of smoking habits for the development of personalized medicine in liver cancer , Kindai University